Sharescart Research Club logo
Products
Research
Tools
About
Join Channel
Consolidated Standalone

Cella Space

₹14.2 -0.6 | 4.3%

Market Cap ₹29 Cr.

Stock P/E 0.6

P/B 0.9

Current Price ₹14.2

Book Value ₹ 16.1

Face Value 10

52W High ₹19.3

Dividend Yield 0%

52W Low ₹ 9.1

Edit Ratio

Cella Space Research see more...

Overview Inc. Year: 1991Industry: Paper & Paper Products

Cella Space Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Cella Space Quarterly Results

#(Fig in Cr.) Mar 2018 Jun 2018 Sep 2018 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 1 0 0 2 2 0 0 0 2 0
Other Income 9 0 0 0 0 1 1 2 2 1
Total Income 10 0 0 2 2 1 1 2 3 1
Total Expenditure 0 0 1 2 1 1 1 1 1 1
Operating Profit 10 -0 -0 1 1 0 0 1 2 0
Interest 0 1 0 1 1 1 0 0 1 0
Depreciation 1 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses -24 -0 6 -0 0 54 0 -1 0 0
Profit Before Tax -16 -1 5 -0 0 53 0 0 1 0
Provision for Tax -3 0 0 0 0 3 0 -0 0 0
Profit After Tax -12 -1 5 -0 0 50 0 1 1 0
Adjustments 12 1 0 0 0 -0 0 0 0 -0
Profit After Adjustments 0 0 5 -0 0 50 0 1 1 0
Adjusted Earnings Per Share -7.2 -0.6 2.8 -0.2 0.1 25.1 0.1 0.3 0.7 0.2

Cella Space Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 156 101 28 2 0 3 3 5 7 8 2 2
Other Income 1 1 1 10 4 1 1 1 1 1 3 6
Total Income 157 102 29 12 4 3 4 7 9 9 6 7
Total Expenditure 154 107 44 2 3 2 1 2 2 3 3 4
Operating Profit 3 -5 -15 9 1 1 3 5 6 6 3 3
Interest 6 6 6 2 0 2 1 3 4 4 2 1
Depreciation 4 3 22 2 2 0 1 1 1 1 1 0
Exceptional Income / Expenses -8 -3 0 -16 3 2 0 0 0 -0 53 -1
Profit Before Tax -15 -18 -43 -10 2 1 0 1 1 0 54 1
Provision for Tax -4 -1 -6 -3 -0 0 0 0 0 0 2 0
Profit After Tax -12 -17 -37 -8 2 1 0 1 1 0 51 2
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -12 -17 -37 -8 2 1 0 1 1 0 51 2
Adjusted Earnings Per Share -7.2 -10.3 -22.4 -4.4 1 0.4 0.2 0.5 0.6 0.1 25.5 1.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -75% -26% -8% -35%
Operating Profit CAGR -50% -16% 25% 0%
PAT CAGR 0% 271% 120% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -12% 5% 25% 0%
ROE Average 1041% 347% 208% 85%
ROCE Average 144% 56% 38% 10%

Cella Space Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 42 25 -23 -27 -25 -25 -24 -23 -21 -21 31
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 10 9 18 11 11 18 39 53 49 52 9
Other Non-Current Liabilities 11 10 3 0 1 2 3 5 4 3 0
Total Current Liabilities 58 51 44 33 25 24 12 10 12 7 3
Total Liabilities 120 94 42 17 11 20 30 44 44 42 43
Fixed Assets 58 55 10 8 9 9 27 39 39 38 0
Other Non-Current Assets 3 2 1 0 0 9 2 2 2 2 0
Total Current Assets 58 36 32 9 1 1 1 3 3 2 43
Total Assets 120 94 42 17 11 20 30 44 44 42 43

Cella Space Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 4 4 -12 -13 -7 -2 1 0 1 0 0
Cash Flow from Operating Activities 6 11 -9 9 11 -1 2 5 3 4 -22
Cash Flow from Investing Activities -2 0 1 10 -4 -9 -11 -12 -1 0 96
Cash Flow from Financing Activities -4 -12 6 -13 -2 13 9 8 -4 -3 -50
Net Cash Inflow / Outflow 1 -1 -1 6 4 3 -1 1 -1 0 24
Closing Cash & Cash Equivalent 4 4 -13 -7 -2 1 0 1 0 0 24

Cella Space Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -7.17 -10.31 -22.41 -4.44 1.05 0.45 0.2 0.54 0.56 0.12 25.51
CEPS(Rs) -4.88 -8.31 -8.91 -3.51 2.24 0.67 0.63 1.16 1.3 0.83 25.79
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 19.18 8.87 -13.78 -16.98 -14.53 -12.82 -12.65 -12.11 -10.43 -10.31 15.21
Core EBITDA Margin(%) 1.13 -5.27 -55.05 -45.43 0 8.03 59.52 68.23 67.26 61.57 -6.75
EBIT Margin(%) -5.68 -10.37 -127.88 -507.28 0 91.17 54.55 69.6 63.68 51.72 2249.66
Pre Tax Margin(%) -9.26 -16.31 -147.59 -638.71 0 31.95 11.61 19.37 15.79 3.18 2185.77
PAT Margin (%) -7.13 -15.68 -127.31 -471.39 0 31.95 11.61 19.37 15.35 3.03 2087.92
Cash Profit Margin (%) -4.85 -12.64 -50.62 -372.46 0 47.95 36.66 41.52 35.35 21.49 2111.34
ROA(%) -9.12 -15.9 -54.28 -25.94 13.8 5.64 1.54 2.8 2.58 0.55 120.97
ROE(%) -31.22 -73.51 0 0 0 0 0 0 0 0 1041.18
ROCE(%) -11.08 -16.28 -84.02 -44.43 42.98 30.62 9.01 12.13 12.98 10.95 144.16
Receivable days 68.41 71.94 126.05 575.67 0 44.87 26.76 23.83 22.38 21.26 31.97
Inventory Days 35.58 46.59 68.72 0 0 0 0 0 0 0 0
Payable days 76.65 102.73 190.33 5939.93 0 2144.03 2309.85 1828.95 5027.41 3370.89 2719.88
PER(x) 0 0 0 0 5.39 6.84 27.26 13.24 15.11 71.79 0.37
Price/Book(x) 0.76 1.08 -0.5 -0.44 -0.39 -0.24 -0.43 -0.59 -0.82 -0.81 0.62
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.44 0.54 2.32 28.51 0 16.46 18.22 13.44 10.09 9.58 1.78
EV/Core EBITDA(x) 23.81 -11.05 -4.36 5.04 57.96 52.51 22.89 14.65 12.05 13.31 1.52
Net Sales Growth(%) -23.64 -34.83 -72.56 -94.16 -100 0 21.91 62.89 38.69 5.02 -68.34
EBIT Growth(%) -213.22 -19.49 -230.03 77.68 120.72 43.27 -27.05 107.82 26.9 -14.71 1276.97
PAT Growth(%) -1114.85 -43.87 -117.35 79.17 124.85 -54.95 -55.69 171.66 9.88 -79.25 0
EPS Growth(%) -1114.87 -43.87 -117.35 80.2 123.61 -57.19 -55.68 171.64 4.42 -79.25 0
Debt/Equity(x) 0.93 1.33 -2.35 -1.14 -1 -1.59 -2.04 -2.56 -2.74 -2.78 0.3
Current Ratio(x) 1 0.71 0.73 0.27 0.04 0.05 0.06 0.26 0.22 0.26 12.8
Quick Ratio(x) 0.7 0.52 0.71 0.27 0.04 0.05 0.06 0.26 0.22 0.26 12.8
Interest Cover(x) -1.59 -1.75 -6.49 -3.86 20.97 1.54 1.27 1.39 1.33 1.07 35.21
Total Debt/Mcap(x) 1.62 2.08 4.69 2.7 2.58 6.65 4.76 4.33 3.35 3.41 0.48

Cella Space Shareholding Pattern

# Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 58.49 58.49 58.49 58.5 58.5 58.5 58.5 58.5 58.5 58.5
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 41.51 41.51 41.51 41.5 41.5 41.5 41.5 41.5 41.5 41.5
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.9 times its book value
  • Company has delivered good profit growth of 119% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 347%
  • Debtor days have improved from 3370.89 to 2719.88days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Earnings include an other income of Rs. 3 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Cella Space News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!